|
LOC220729 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.7054135881267E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.80879805262202E-11 |
| Normal-vs-Stage2 |
3.77129999995507E-06 |
| Normal-vs-Stage3 |
1.29563026973756E-13 |
| Normal-vs-Stage4 |
2.12009999556173E-08 |
| Stage1-vs-Stage2 |
8.047600E-01 |
| Stage1-vs-Stage3 |
1.643830E-02 |
| Stage1-vs-Stage4 |
1.561160E-01 |
| Stage2-vs-Stage3 |
5.321500E-02 |
| Stage2-vs-Stage4 |
2.060800E-01 |
| Stage3-vs-Stage4 |
7.486200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.02584607475364E-13 |
| Normal-vs-AfricanAmerican |
6.07259999999554E-05 |
| Normal-vs-Asian |
4.1472999999792E-06 |
| Caucasian-vs-AfricanAmerican |
8.376000E-01 |
| Caucasian-vs-Asian |
1.664380E-01 |
| AfricanAmerican-vs-Asian |
4.562400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.97790003767062E-09 |
| Normal-vs-Female |
1.70319314207745E-12 |
| Male-vs-Female |
6.481200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.36110036972082E-10 |
| Normal-vs-Age(41-60Yrs) |
1.08899556039432E-11 |
| Normal-vs-Age(61-80Yrs) |
9.21139997611675E-09 |
| Normal-vs-Age(81-100Yrs) |
1.0519000004372E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.715400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.449800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.921000E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.813600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.199860E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.137900E-03 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.17699999996535E-06 |
| Classical-VS-Follicular |
9.498100E-03 |
| Classical-VS-Other |
7.697600E-01 |
| Classical-VS-Normal |
2.12874162741628E-12 |
| Tall-VS-Follicular |
3.6355000010424E-08 |
| Tall-VS-Other |
3.047000E-01 |
| Tall-VS-Normal |
2.74225087082414E-14 |
| Follicular-VS-Other |
3.071600E-01 |
| Follicular-VS-Normal |
6.44709999999549E-05 |
| Other-VS-Normal |
6.895700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.44719952372463E-10 |
| Normal-vs-N1 |
3.42310000001067E-06 |
| N0-vs-N1 |
8.133200E-01 |
|
|
